Search for: "Stone v. Illinois Central R. Co"
Results 1 - 12
of 12
Sort by Relevance
|
Sort by Date
19 Jul 2022, 6:14 am
Stone Oil Distributor, LLC, No. 14-30891 (5th Cir. [read post]
9 Jun 2020, 6:01 am
Darby (1941) Stone Court: Wickard v. [read post]
5 Jun 2020, 6:00 am
Darby (1941) Stone Court: Wickard v. [read post]
25 Dec 2018, 3:00 am
__X__ The text of any contract or other document that is central to the argument. [read post]
1 May 2016, 1:49 pm
So RIME sued Moschino and Scott (California Central District Court, 2:2015cv05900) claiming copyright infringement for misappropriation of his artwork. [read post]
18 Dec 2013, 7:09 am
American Access Casualty Co. v. [read post]
15 Dec 2011, 6:25 am
Dukes and AT&T Mobility v. [read post]
14 Jul 2011, 9:23 am
DEATHERAGE New York: Oxford University Press, c2011 K3593.5.C37 D43 2011 See Catalog Central-local government relations -- Developing countries DECENTRALIZATION AND RECENTRALIZATION IN THE DEVELOPING WORLD / J. [read post]
13 Jul 2011, 11:49 am
DEATHERAGE New York: Oxford University Press, c2011 K3593.5.C37 D43 2011 See Catalog Central-local government relations -- Developing countries DECENTRALIZATION AND RECENTRALIZATION IN THE DEVELOPING WORLD / J. [read post]
7 Apr 2010, 3:44 pm
The following is a summary review of articles from all over the nation concerning environmental law settlements, decisions, regulatory actions and lawsuits filed during the past week. [read post]
14 Mar 2010, 10:47 pm
– Charlotte Observer, March 8, 2010 Norfolk Southern Railway Co. has agreed to pay a $4 million penalty for a 2005 chlorine and diesel fuel spill that killed nine people and polluted a creek in western South Carolina, the federal government said Monday. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
